Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE
Spiros Georgakis, Katerina Gkirtzimanaki, Garyfalia Papadaki, Hariklia Gakiopoulou, Elias Drakos, Maija-Leena Eloranta, Manousos Makridakis, Georgia Kontostathi, Jerome Zoidakis, Eirini Baira, Lars Rönnblom, Dimitrios T. Boumpas, Prodromos Sidiropoulos, Panayotis Verginis, George Bertsias
Spiros Georgakis, Katerina Gkirtzimanaki, Garyfalia Papadaki, Hariklia Gakiopoulou, Elias Drakos, Maija-Leena Eloranta, Manousos Makridakis, Georgia Kontostathi, Jerome Zoidakis, Eirini Baira, Lars Rönnblom, Dimitrios T. Boumpas, Prodromos Sidiropoulos, Panayotis Verginis, George Bertsias
View: Text | PDF
Research Article Inflammation

NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE

  • Text
  • PDF
Abstract

IL-33, a nuclear alarmin released during cell death, exerts context-specific effects on adaptive and innate immune cells, eliciting potent inflammatory responses. We screened blood, skin, and kidney tissues from patients with systemic lupus erythematosus (SLE), a systemic autoimmune disease driven by unabated type I IFN production, and found increased amounts of extracellular IL-33 complexed with neutrophil extracellular traps (NETs), correlating with severe, active disease. Using a combination of molecular, imaging, and proteomic approaches, we show that SLE neutrophils, activated by disease immunocomplexes, release IL-33–decorated NETs that stimulate robust IFN-α synthesis by plasmacytoid DCs in a manner dependent on the IL-33 receptor ST2L. IL33-silenced neutrophil-like cells cultured under lupus-inducing conditions generated NETs with diminished interferogenic effect. Importantly, NETs derived from patients with SLE are enriched in mature bioactive isoforms of IL-33 processed by the neutrophil proteases elastase and cathepsin G. Pharmacological inhibition of these proteases neutralized IL-33–dependent IFN-α production elicited by NETs. We believe these data demonstrate a novel role for cleaved IL-33 alarmin decorating NETs in human SLE, linking neutrophil activation, type I IFN production, and end-organ inflammation, with skin pathology mirroring that observed in the kidneys.

Authors

Spiros Georgakis, Katerina Gkirtzimanaki, Garyfalia Papadaki, Hariklia Gakiopoulou, Elias Drakos, Maija-Leena Eloranta, Manousos Makridakis, Georgia Kontostathi, Jerome Zoidakis, Eirini Baira, Lars Rönnblom, Dimitrios T. Boumpas, Prodromos Sidiropoulos, Panayotis Verginis, George Bertsias

×

Figure 3

Stimulation of neutrophils, derived from patients with SLE, with nucleic acid-containing ICs led to increased IL-33 expression and IL-33 decoration of NETs.

Options: View larger image (or click on image) Download as PowerPoint
Stimulation of neutrophils, derived from patients with SLE, with nucleic...
(A) Real-time PCR was performed to confirm differential gene expression of IL33 in resting versus IC-treated neutrophils from the peripheral blood of patients with SLE (n = 6). Data were normalized using the average value of resting neutrophils ΔCt (IL33 Ct minus GAPDH Ct) values. Each dot represents a different donor and bar plots show the mean ± SEM expression. *P < 0.05 (2-tailed, paired t test). (B) Western immunoblotting was performed to examine intracellular IL-33 protein in unstimulated and IC-treated neutrophils from patients with SLE (n = 5). Results were normalized and quantified via densitometry followed by calculation of the relative expression of IL-33 over MPO (loading control). Each dot represents a different donor and bar plots show the mean ± SEM expression. *P < 0.05 (2 tailed, paired t test) (left panel). Representative blot (n = 2 experiments) from unstimulated and IC-treated neutrophils obtained from 3 patients (right panel). (C) Unstimulated or IC-treated SLE neutrophils were cultured for 3 hours and then stained with anti–citrullinated histone-3, anti–IL-33 (IL-33) antibodies, and DAPI for DNA. Representative confocal images (scale bar: 30 μm) in 1 of 3 replicates demonstrate that IC-treated SLE neutrophils generate abundant amounts of IL-33–decorated NETs. (D) Western immunoblotting for IL-33 protein in spontaneously released versus IC-mediated NETs precipitates derived from SLE neutrophils (n = 3).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts